Immunic | VTL - Ebit


Immunic reported $-23.33M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
BioMarin Pharmaceutical USD 129.65M 68.74M Mar/2026
Cipla INR 6.14B 3.63B Mar/2026
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD 56.04M 63.94M Dec/2025
CSL USD 2.64B 116M Dec/2025
Enanta Pharmaceuticals USD -23.54M 6.31M Dec/2024
Grifols EUR 320.55M 91.01M Dec/2025
Immunic USD -23.33M 2.67M Dec/2025
Insmed USD -200.28M 49.43M Mar/2026
Omeros USD -48.15M 7.25M Sep/2023
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quidel USD -27.4M 9.9M Mar/2026
Ultragenyx Pharmaceutical USD -216M 102M Mar/2026
United Therapeutics USD 325.8M 340.4M Mar/2026
Xoma USD -10.08M 4.4M Jun/2024